CION Ameerpet
A pituitary tumour (pituitary adenoma) is one of the most common growths found at the base of the brain — and the vast majority are non-cancerous. With the right hormone tests, a focused MRI, and a clear plan, most people do very well.
The pituitary is a pea-sized gland that sits in a tiny bony pocket at the base of the brain, just behind the eyes. Despite its size, it is the body's "master gland" — it directs the thyroid, the adrenal glands, growth, periods, fertility, and more. A pituitary tumour is a growth in this gland. The medical name for the common type is a pituitary adenoma.
The reassuring headline first: the overwhelming majority of pituitary tumours are benign — non-cancerous — and they do not spread to other organs. A truly cancerous pituitary tumour (a pituitary carcinoma) is extremely rare. So while a brain scan finding can be frightening, this is usually a tumour, not brain cancer. That distinction shapes everything about how it is treated.
Pituitary tumours cause trouble in two main ways. First, by their size and position — a larger tumour can press upward on the optic nerves (affecting vision) or squeeze the healthy pituitary tissue (causing hormone deficiency). Second, by their hormone activity — some tumours pump out too much of a hormone, which produces very specific symptoms. Understanding which of these applies to you is the first job of your care team. For a wider picture of how the gland fits into brain tumour care, see our brain cancer and tumour hub.
Pituitary adenomas are common — small ones are found incidentally on brain scans done for unrelated reasons surprisingly often. According to NCCN guidance on central nervous system tumours, the great majority of pituitary adenomas are benign, and many small, non-functioning ones never need treatment at all — they are simply monitored with periodic MRI.
Doctors describe a pituitary tumour in two ways at once — by its size, and by whether it makes a hormone (functioning) or not (non-functioning). Both labels guide the treatment plan.
A microadenoma is smaller than 10 mm (1 cm). Because they are small, they rarely press on nearby nerves. Many are non-functioning and cause no symptoms at all, often discovered by chance on a scan done for another reason. These are frequently managed with simple watchful monitoring — a repeat MRI after a period of time — rather than immediate treatment.
A macroadenoma is 10 mm or larger. Their size makes them more likely to press upward on the optic nerves (threatening vision) or to crush the normal gland (causing hormone deficiency). A growing macroadenoma, or one already affecting vision, usually needs active treatment — medication, coordinated surgery, or radiation depending on the type.
These secrete excess hormone, and the symptoms point to which one. A prolactinoma (excess prolactin) is the most common — learn more about prolactinoma and other functioning pituitary tumours. Others overproduce growth hormone (causing acromegaly), or the hormone that drives cortisol (causing Cushing's disease). The treatment is tailored to the specific hormone.
These do not over-secrete a hormone, so they tend to stay silent until they grow large enough to press on something. They usually announce themselves through vision changes, headaches, or signs of under-production of hormones (fatigue, low libido) caused by pressure on the healthy gland. They are the most common type found in adults.
Most of the symptoms below have common, benign explanations — tiredness, stress, ageing eyes, hormonal ups and downs. A symptom on its own rarely means a pituitary tumour. What matters is a cluster of clues, or a clear red flag like vision loss. The most important warning signs are:
When to act quickly: sudden, severe headache with new vision loss or double vision can rarely signal bleeding into a pituitary tumour (pituitary apoplexy) — this is an emergency. For the full hormone-by-hormone picture, read the hormonal symptoms of a pituitary tumour, or speak to a CION specialist.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether your scan shows a microadenoma to monitor or a macroadenoma that needs a plan, our team explains your options clearly — with transparent costs and no pressure.
Unlike most tumours, a pituitary tumour is usually identified without a biopsy first. The diagnosis comes from three pieces of information that fit together. CION coordinates this whole workup so you are not sent from clinic to clinic.
This is a focused MRI of the small region where the gland sits, taken in thin slices with contrast. It is far more sensitive than a routine brain scan for this area. It shows the tumour's size (micro vs macroadenoma), its shape, and crucially whether it is touching or lifting the optic nerves.
A panel of blood tests checks each pituitary hormone — prolactin, growth hormone (and IGF-1), the cortisol pathway, thyroid, and the sex hormones. This reveals whether the tumour is functioning (over-producing) or whether the gland is under-producing because of pressure. This pattern, more than anything, points to the tumour type.
If the MRI shows the tumour near the optic nerves, a simple, painless visual field test maps your side vision. It catches early loss you may not have noticed and gives a baseline to track over time.
Every result is then brought to CION's multidisciplinary tumour board, where endocrine, radiation, and surgical perspectives are weighed together before a single recommendation is made.
There is no single treatment — the right approach depends on the tumour type, its size, and whether it affects vision or hormones. The four main routes are below. Many people need only one of them.
For small, non-functioning microadenomas causing no symptoms, the safest plan is often active surveillance — periodic MRI to confirm the tumour is not growing. Many never change and never need treatment.
This is where pituitary tumours are unusual: a prolactinoma is usually treated with tablets alone. Dopamine-agonist medication can shrink the tumour and normalise prolactin without any surgery, often restoring periods and fertility. Some growth-hormone tumours can also be controlled with medication. CION's medical team manages this therapy and monitors your response with repeat hormone tests.
When a tumour presses on the optic nerves, is growing, or secretes a hormone other than prolactin, surgery is usually the answer. The standard operation is trans-sphenoidal (through-the-nose) pituitary surgery — reaching the gland through the nasal passage, with no visible incision. CION does not perform neurosurgery in-house; we arrange and coordinate this procedure with accredited neurosurgical partners, and manage your hormone and recovery care around it.
If a tumour is left behind after surgery, recurs, or cannot be safely operated on, focused radiation (stereotactic radiosurgery or fractionated radiotherapy) can control its growth over time. This is delivered as part of coordinated specialist radiation care and planned to protect the optic nerves and surrounding structures.
If the tumour or its treatment leaves the gland unable to make enough of a hormone, hormone replacement (thyroid, cortisol, sex hormones, or growth hormone) keeps you well. This is straightforward and lifelong follow-up is built into your CION plan.
A prolactinoma — the most common functioning pituitary tumour — can often be treated with medication alone. Endocrine Society and NCCN guidance recognise dopamine-agonist therapy as first-line treatment for most prolactinomas, frequently shrinking the tumour and restoring fertility without an operation.
Pituitary tumour decisions sit at the crossroads of three specialties, and it is worth pausing for a second opinion when:
CION offers a free written second opinion. Bring your MRI and hormone results, and we will review them and explain your options. Start your brain tumour treatment in Hyderabad with a clear, unhurried plan — call 18002028726 or request a callback.
Get a free written second opinion from CION — especially valuable before agreeing to pituitary surgery, or if a full hormone panel has not yet been done.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Almost always, no. The vast majority of pituitary tumours are pituitary adenomas — benign (non-cancerous) growths that do not spread to other parts of the body. Cancerous pituitary tumours (pituitary carcinomas) are extremely rare. "Benign" does not mean harmless, though: an adenoma can still cause real problems by pressing on nearby structures such as the optic nerves, or by making too much (or too little) of a hormone. The right word for most of these is "tumour," not "cancer." Treatment focuses on relieving pressure and correcting hormone levels — not chemotherapy.
The difference is simply size. A microadenoma is smaller than 10 mm (1 cm) across; a macroadenoma is 10 mm or larger. Size matters because larger tumours are more likely to press on the optic nerves (causing vision loss) or on the rest of the pituitary gland (causing hormone deficiency). Small, non-functioning microadenomas that cause no symptoms are often simply monitored with periodic MRI. A growing macroadenoma, or any adenoma pressing on the optic pathway, usually needs active treatment.
The two classic red flags are new vision changes — especially losing the outer (peripheral) edges of your vision in both eyes — and persistent headaches. Hormone-related clues are just as important: irregular or stopped periods, milky nipple discharge, low sex drive or erectile difficulty, unexplained weight gain, fatigue, feeling cold, or new growth of the hands, feet, or jaw in adults. None of these alone proves a tumour — they have common, benign causes — but a combination, or vision loss, deserves prompt assessment with hormone blood tests and a pituitary MRI.
Diagnosis rests on three things working together: a pituitary-protocol MRI (a focused MRI of the small sella region, with contrast), a panel of hormone blood tests to see whether the tumour is overproducing or suppressing a hormone, and a visual field test if the tumour is near the optic nerves. Unlike most cancers, a biopsy is usually not needed first — the imaging and hormone pattern together tell the team the tumour type. CION coordinates this full workup and reviews every case at a multidisciplinary tumour board before recommending a plan.
No. Treatment depends on the type. A prolactinoma (the most common functioning type) is usually treated with medication alone — tablets that shrink the tumour and normalise the prolactin level — without any surgery. Small, non-functioning tumours that cause no symptoms are often safely watched with regular MRI. Surgery — most often trans-sphenoidal (through-the-nose) pituitary surgery, coordinated with accredited neurosurgical partners — is reserved for tumours pressing on the optic nerves, large or growing tumours, or hormone-secreting tumours other than prolactinomas.
It can, and this is one of the most important parts of long-term care. A large tumour — or sometimes its treatment — can leave the pituitary unable to make enough of certain hormones (a condition called hypopituitarism). This is managed with hormone replacement, which can include thyroid hormone, cortisol (a steroid), sex hormones, or growth hormone, depending on what is missing. Many people live completely normal lives on replacement therapy. At CION, endocrine follow-up is built into the plan, and hormone levels are rechecked regularly after any treatment so replacement can be adjusted as needed.
It can, but the effect is often reversible once the tumour is treated. Prolactinomas, for example, raise prolactin and stop ovulation or lower sperm production — and treating the prolactinoma with medication frequently restores fertility. Other tumours can disrupt the hormones that drive the ovaries or testes. Because fertility is so often involved, hormone testing and a frank conversation about family planning are part of the assessment. If you are trying to conceive, or are pregnant, tell your team early — some treatments are adjusted during pregnancy. Read more about hormonal symptoms of a pituitary tumour.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.